NEOG|EPS $0.09|Rev $211.2M|Net Loss $17.0MNeogen Corporation (NASDAQ: NEOG) reported Q3 2026 adjusted earnings of $0.09 per share as the food and animal safety products company navigated a challenging revenue environment. The company generated $211.2M in revenue for the quarter, representing a 4.4% decrease from the $221.0M recorded in Q3 2025. Despite the topline headwinds, Neogen earned $19.4M during the period, on an adjusted basis.
The company’s core revenue growth was just barely positive at +0.1% for the quarter, suggesting that currency fluctuations and portfolio changes weighed on reported results. Food Safety, Neogen’s largest division, provided a bright spot with $156.7M in revenue, up 2.6% year-over-year. The segment’s performance underscores continued demand for the company’s diagnostic test kits and safety solutions across the global food supply chain.
For the full year, management expects revenue of $857.0M to $860.0M as Neogen works to stabilize its business following recent portfolio adjustments and integration activities. The guidance provides investors with a clear view of expected performance as the company closes out its fiscal year.
Wall Street consensus stands at 4 Buy, 4 Hold, zero Sell, reflecting a divided view among analysts covering the stock. The mixed ratings suggest market observers are weighing Neogen’s established market position in food safety against near-term revenue growth challenges.
A detailed analysis of Neogen Corporation’s quarter follows shortly on AlphaStreet.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.